Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Dartmouth › NPI 1467412429
Physician

Dunphy, Laura

Dunphy, Laura was paid $200K by Medicaid between Mar 2018 and Mar 2023, across 15 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.

33Billing provider infoDUNPHY, LAURA
DARTMOUTH, MA 02747
33aNPI1467412429assigned 03/24/2006
33bProvider typePediatrics Physician
28Total paid$200K
24GClaims5,303
24DCodes billed15
24AFirst – last monthMar 2018 – Mar 2023
Compared with peers

Next to other Pediatrics Physician providers in Massachusetts

Rank by total paid#286 of 1,273
Median peer was paid$24K
This provider vs. median8.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018899$29K
20191,102$40K
2020854$27K
20211,033$41K
20221,262$55K
2023153$8K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 35% 1,227 1,185 $69K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28% 552 527 $56K
90460 Immunization administration through 18 years of age via any route, first or only component 12% 900 807 $25K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 4.8% 1,071 1,071 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.3% 180 179 $9K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4.2% 100 100 $8K
96127 3.1% 604 604 $6K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2.3% 49 49 $5K
99177 2.2% 233 233 $4K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 136 136 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 32 32 $2K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 142 142 $1K
3 more codes
92552 <1% 52 $963.44
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 12 $324.99
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 13 $293.52

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.